The weekly litigation news digest is live. Subscribe now

IP Verse

Alt-803 In Combination With Anti-Cd38 Antibody For Cancer Therapies

Patent No. EP3601363 (titled "Alt-803 In Combination With Anti-Cd38 Antibody For Cancer Therapies") was filed by Altor Bioscience on Mar 30, 2018. The application was issued on Jun 15, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CYTUNE PHARMAMar 15, 2023MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3601363

ALTOR BIOSCIENCE
Application Number
EP18776459A
Filing Date
Mar 30, 2018
Status
Opposition Rejected
Oct 11, 2024
Publication Date
Jun 15, 2022
External Links
Slate, Register, Google Patents